Clal Biotechnology reported ILS-857000 in Gross Profit on Sales for its fiscal quarter ending in June of 2022.


Gross Profit On Sales Change Date
Clal Biotechnology ILS -857000 1.42M Jun/2022
Compugen USD -408000 1.2M Jun/2025
Life Technologies -15380000 1.88M Jun/2025
RedHill Biopharma USD 584K 0 Jun/2024